Targeted endothelial nanomedicine for common acute pathological conditions

Journal of Controlled Release

Volumn 219, Issue , 2015, Pages 576-595

  Shuvaev, Vladimir V ^a,b   Brenner, Jacob S ^a,b   Muzykantov, Vladimir R ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b University of Pennsylvania   (United States)

Author keywords

Drug delivery; Vascular immunotargeting

Indexed keywords

ANIMALS; BINDING SITES; BINS; CELL ADHESION; CELL MEMBRANES; DISEASE CONTROL; DRUG DELIVERY; ENDOTHELIAL CELLS; EPITOPES; LIGANDS; MEDICAL NANOTECHNOLOGY; MOLECULES;

ANTI-INFLAMMATORIES; BLOOD AND TISSUES; CELL ADHESION MOLECULES; DIFFERENT DOMAINS; EXPERIMENTAL MODELS; PATHOLOGICAL CONDITIONS; THERAPEUTIC EFFECTS; VASCULAR IMMUNOTARGETING;

BLOOD VESSELS;

ACTIN; ANTICOAGULANT AGENT; ANTIOXIDANT; CD31 ANTIGEN; CELL ADHESION MOLECULE; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; MYOSIN; NANOCARRIER; PEPTIDASE; SOMATOMEDIN B RECEPTOR; SPHINGOMYELIN PHOSPHODIESTERASE; THROMBOMODULIN; UROKINASE; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BLOOD PRESSURE; BLOOD VESSEL TONE; BLOOD VESSEL WALL; CELL MEMBRANE; DRUG DELIVERY SYSTEM; ENZYME REPLACEMENT; HOST RESISTANCE; HUMAN; INFLAMMATION; NANOMEDICINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; VASCULAR ENDOTHELIUM; ANIMAL; ENDOTHELIUM; ENDOTHELIUM CELL; METABOLISM;

ANIMALS; DRUG DELIVERY SYSTEMS; ENDOTHELIAL CELLS; ENDOTHELIUM; HUMANS; NANOMEDICINE;

EID: 84947231281     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.09.055     Document Type: Article

References (323)

1. R.E. Pagano, and J.N. Weinstein Interactions of liposomes with mammalian cells Annu. Rev. Biophys. Bioeng. 7 1 1978 435 468
2. G. Gregoriadis Liposomes in therapeutic and preventive medicine: the development of the drug-carrier concept Ann. N. Y. Acad. Sci. 308 1 1978 343 370
3. B.E. Ryman, and D.A. Tyrrell Liposomes - methodology and applications Front. Biol. 48 1979 549 574
4. R.L. Juliano Drug delivery systems: a brief review Can. J. Physiol. Pharmacol. 56 5 1978 683 690
5. R.S. Langer, and N.A. Peppas Present and future applications of biomaterials in controlled drug delivery systems Biomaterials 2 4 1981 201 214
6. M. Elsabahy, and K.L. Wooley Design of polymeric nanoparticles for biomedical delivery applications Chem. Soc. Rev. 41 7 2012 2545 2561
7. J.L. Perry, K.P. Herlihy, M.E. Napier, and J.M. Desimone PRINT: a novel platform toward shape and size specific nanoparticle theranostics Acc. Chem. Res. 44 10 2011 990 998
8. R.R. Sawant, and V.P. Torchilin Multifunctionality of lipid-core micelles for drug delivery and tumour targeting Mol. Membr. Biol. 27 7 2010 232 246
9. S. Venkataraman, J.L. Hedrick, Z.Y. Ong, C. Yang, P.L. Ee, P.T. Hammond, and Y.Y. Yang The effects of polymeric nanostructure shape on drug delivery Adv. Drug Deliv. Rev. 63 14-15 2011 1228 1246
10. D.G. van der Poll, H.M. Kieler-Ferguson, W.C. Floyd, S.J. Guillaudeu, K. Jerger, F.C. Szoka, and J.M. Frechet Design, synthesis, and biological evaluation of a robust, biodegradable dendrimer Bioconjug. Chem. 21 4 2010 764 773
11. F. Szoka Jr., and D. Papahadjopoulos Comparative properties and methods of preparation of lipid vesicles (liposomes) Annu. Rev. Biophys. Bioeng. 9 1 1980 467 508
12. V. Percec, D.A. Wilson, P. Leowanawat, C.J. Wilson, A.D. Hughes, M.S. Kaucher, D.A. Hammer, D.H. Levine, A.J. Kim, F.S. Bates, K.P. Davis, T.P. Lodge, M.L. Klein, R.H. DeVane, E. Aqad, B.M. Rosen, A.O. Argintaru, M.J. Sienkowska, K. Rissanen, S. Nummelin, and J. Ropponen Self-assembly of Janus dendrimers into uniform dendrimersomes and other complex architectures Science 328 5981 2010 1009 1014
13. A.O. Eniola, and D.A. Hammer Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes II: effect of degradation on targeting activity Biomaterials 26 6 2005 661 670
14. B.M. Discher, Y.Y. Won, D.S. Ege, J.C. Lee, F.S. Bates, D.E. Discher, and D.A. Hammer Polymersomes: tough vesicles made from diblock copolymers Science 284 5417 1999 1143 1146
15. O.C. Farokhzad, and R. Langer Impact of nanotechnology on drug delivery ACS Nano 3 1 2009 16 20
16. M. Liong, J. Lu, M. Kovochich, T. Xia, S.G. Ruehm, A.E. Nel, F. Tamanoi, and J.I. Zink Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery ACS Nano 2 5 2008 889 896
17. Y. Wang, C.A. Mirkin, and S.J. Park Nanofabrication beyond electronics ACS Nano 3 5 2009 1049 1056
18. C.L. Bayer, and N.A. Peppas Advances in recognitive, conductive and responsive delivery systems J. Control. Release 132 3 2008 216 221
19. H.M. Kieler-Ferguson, J.M. Frechet, and F.C. Szoka Jr. Clinical developments of chemotherapeutic nanomedicines: polymers and liposomes for delivery of camptothecins and platinum (II) drugs Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 5 2 2013 130 138
20. E.V. Batrakova, and A.V. Kabanov Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers J. Control. Release 130 2 2008 98 106
21. S.A. Wickline, A.M. Neubauer, P.M. Winter, S.D. Caruthers, and G.M. Lanza Molecular imaging and therapy of atherosclerosis with targeted nanoparticles J. Magn. Reson. Imaging 25 4 2007 667 680
22. A.J. Hamilton, S.L. Huang, D. Warnick, M. Rabbat, B. Kane, A. Nagaraj, M. Klegerman, and D.D. McPherson Intravascular ultrasound molecular imaging of atheroma components in vivo J. Am. Coll. Cardiol. 43 3 2004 453 460
23. D.P. McIntosh, X.Y. Tan, P. Oh, and J.E. Schnitzer Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery Proc. Natl. Acad. Sci. U. S. A. 99 4 2002 1996 2001
24. V.R. Muzykantov Immunotargeting of drugs to the pulmonary vascular endothelium as a therapeutic strategy Pathophysiology 5 1998 15 33
25. M.A. Moses, H. Brem, and R. Langer Advancing the field of drug delivery: taking aim at cancer Cancer Cell 4 5 2003 337 341
26. C. Kirby, and G. Gregoriadis Dehydration-rehydration vesicles: a simple method for high yield drug entrapment in liposomes Nat. Biotechnol. 2 11 1984 979 984
27. J.W. Park, K. Hong, D.B. Kirpotin, G. Colbern, R. Shalaby, J. Baselga, Y. Shao, U.B. Nielsen, J.D. Marks, D. Moore, D. Papahadjopoulos, and C.C. Benz Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery Clin. Cancer Res. 8 4 2002 1172 1181
28. V.R. Muzykantov Biomedical aspects of targeted delivery of drugs to pulmonary endothelium Expert Opin. Drug Deliv. 2 5 2005 909 926
29. A.B. Fisher Redox signaling across cell membranes Antioxid. Redox Signal. 11 6 2009 1 8
30. B.H. Segal, W. Han, J.J. Bushey, M. Joo, Z. Bhatti, J. Feminella, C.G. Dennis, R.R. Vethanayagam, F.E. Yull, M. Capitano, P.K. Wallace, H. Minderman, J.W. Christman, M.B. Sporn, J. Chan, D.C. Vinh, S.M. Holland, L.R. Romani, S.L. Gaffen, M.L. Freeman, and T.S. Blackwell NADPH oxidase limits innate immune responses in the lungs in mice PLoS One 5 3 2010 e9631 9631-9614
31. Y.M. Janssen-Heininger, B.T. Mossman, N.H. Heintz, H.J. Forman, B. Kalyanaraman, T. Finkel, J.S. Stamler, S.G. Rhee, and A. van der Vliet Redox-based regulation of signal transduction: principles, pitfalls, and promises Free Radic. Biol. Med. 45 1 2008 1 17
32. A. van der Vliet NADPH oxidases in lung biology and pathology: host defense enzymes, and more Free Radic. Biol. Med. 44 6 2008 938 955
33. S.G. Rhee Cell signaling. H2O2, a necessary evil for cell signaling Science 312 5782 2006 1882 1883
34. H.J. Forman, M. Maiorino, and F. Ursini Signaling functions of reactive oxygen species Biochemistry 49 5 2010 835 842
35. M.I. Cybulsky, and M.A. Gimbrone Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis Science 251 4995 1991 788 791
36. K. Iiyama, L. Hajra, M. Iiyama, H. Li, M. DiChiara, B.D. Medoff, and M.I. Cybulsky Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation Circ. Res. 85 2 1999 199 207
37. S. Muro, and V.R. Muzykantov Targeting of antioxidant and anti-thrombotic drugs to endothelial cell adhesion molecules Curr. Pharm. Des. 11 18 2005 2383 2401
38. W.C. Aird Endothelium and haemostasis Hamostaseologie 35 1 2015 11 16
39. G. Molema, and W.C. Aird Vascular heterogeneity in the kidney Semin. Nephrol. 32 2 2012 145 155
40. F. Braet, and E. Wisse Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review Comp. Hepatol. 1 1 2002 1
41. J. Reichen The role of the sinusoidal endothelium in liver function News Physiol. Sci. 14 1999 117 121
42. R.V. Stan Endothelial stomatal and fenestral diaphragms in normal vessels and angiogenesis J. Cell. Mol. Med. 11 4 2007 621 643
43. A.I. Schafer Vascular endothelium: in defense of blood fluidity J. Clin. Invest. 99 6 1997 1143 1144
44. V.W. van Hinsbergh Endothelium - role in regulation of coagulation and inflammation Semin. Immunopathol. 34 1 2012 93 106
45. N.M. Goldenberg, and W.M. Kuebler Endothelial cell regulation of pulmonary vascular tone, inflammation, and coagulation Comp. Physiol. 5 2 2015 531 559
46. P.M. Vanhoutte, Endothelium-derived free radicals: for worse and for better. J. Clin. Invest. 107(1) (2001) 23-25.
47. M. Simionescu, A. Gafencu, and F. Antohe Transcytosis of plasma macromolecules in endothelial cells: a cell biological survey Microsc. Res. Tech. 57 5 2002 269 288
48. M.A. Gimbrone, Jr., Vascular endothelium, hemodynamic forces, and atherogenesis. Am. J. Pathol. 155(1) (1999) 1-5.
49. M. Feletou, R. Kohler, and P.M. Vanhoutte Nitric oxide: orchestrator of endothelium-dependent responses Ann. Med. 44 7 2012 694 716
50. D.P. Sullivan, and W.A. Muller Neutrophil and monocyte recruitment by PECAM, CD99, and other molecules via the LBRC Semin. Immunopathol. 36 2 2014 193 209
51. Y. Dong, K.T. Love, J.R. Dorkin, S. Sirirungruang, Y. Zhang, D. Chen, R.L. Bogorad, H. Yin, Y. Chen, A.J. Vegas, C.A. Alabi, G. Sahay, K.T. Olejnik, W. Wang, A. Schroeder, A.K. Lytton-Jean, D.J. Siegwart, A. Akinc, C. Barnes, S.A. Barros, M. Carioto, K. Fitzgerald, J. Hettinger, V. Kumar, T.I. Novobrantseva, J. Qin, W. Querbes, V. Koteliansky, R. Langer, and D.G. Anderson Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates Proc. Natl. Acad. Sci. U. S. A. 111 11 2014 3955 3960
52. A.C. Anselmo, V. Gupta, B.J. Zern, D. Pan, M. Zakrewsky, V. Muzykantov, and S. Mitragotri Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells ACS Nano 7 12 2013 11129 11137
53. F. Danhier, O. Feron, and V. Preat To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery J. Control. Release 148 2 2010 135 146
54. P. Oh, Y. Li, J. Yu, E. Durr, K.M. Krasinska, L.A. Carver, J.E. Testa, and J.E. Schnitzer Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy Nature 429 6992 2004 629 635
55. J.E. Schnitzer Vascular targeting as a strategy for cancer therapy N. Engl. J. Med. 339 7 1998 472 474
56. S.J. Kennel, R. Lee, S. Bultman, and G. Kabalka Rat monoclonal antibody distribution in mice: an epitope inside the lung vascular space mediates very efficient localization Int. J. Rad. Appl. Instrum. B 17 2 1990 193 200
57. D.D. Spragg, D.R. Alford, R. Greferath, C.E. Larsen, K.D. Lee, G.C. Gurtner, M.I. Cybulsky, P.F. Tosi, C. Nicolau, and M.A. Gimbrone Jr. Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system Proc. Natl. Acad. Sci. U. S. A. 94 16 1997 8795 8800
58. R.B. Huang, S. Mocherla, M.J. Heslinga, P. Charoenphol, and O. Eniola-Adefeso Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery Mol. Membr. Biol. 27 7 2010 312 327
59. A. Corti, F. Pastorino, F. Curnis, W. Arap, M. Ponzoni, and R. Pasqualini Targeted drug delivery and penetration into solid tumors Med. Res. Rev. 32 5 2012 1078 1091
60. C.O. Noble, D.B. Kirpotin, M.E. Hayes, C. Mamot, K. Hong, J.W. Park, C.C. Benz, J.D. Marks, and D.C. Drummond Development of ligand-targeted liposomes for cancer therapy Expert Opin. Ther. Targets 8 4 2004 335 353
61. W. Xia, and P.S. Low Folate-targeted therapies for cancer J. Med. Chem. 53 19 2010 6811 6824
62. V.R. Muzykantov, and S.M. Danilov V. Torchilin, Targeted Delivery of Imaging Agents 1995 CRC Press Roca Baton, Florida 465 485
63. D.J. Goetz, M.E. El-sabban, D.A. Hammer, and B.U. Pauli Lu-ECAM-1-mediated adhesion of melanoma cells to endothelium under conditions of flow Int. J. Cancer 65 2 1996 192 199
64. X. Huang, G. Molema, S. King, L. Watkins, T.S. Edgington, and P.E. Thorpe Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature Science 275 5299 1997 547 550
65. R.V. Stan, L. Ghitescu, B.S. Jacobson, and G.E. Palade Isolation, cloning, and localization of rat PV-1, a novel endothelial caveolar protein J. Cell Biol. 145 6 1999 1189 1198
66. D. Rajotte, W. Arap, M. Hagedorn, E. Koivunen, R. Pasqualini, and E. Ruoslahti Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display J. Clin. Invest. 102 2 1998 430 437
67. S.M. Danilov, V.R. Muzykantov, A.V. Martynov, E.N. Atochina, I. Sakharov, I.N. Trakht, and V.N. Smirnov Lung is the target organ for a monoclonal antibody to angiotensin-converting enzyme Lab. Investig. 64 1 1991 118 124
68. R. Pasqualini, D.M. McDonald, and W. Arap Vascular targeting and antigen presentation Nat. Immunol. 2 7 2001 567 568
69. V.R. Muzykantov, E.N. Atochina, H. Ischiropoulos, S.M. Danilov, and A.B. Fisher Immunotargeting of antioxidant enzyme to the pulmonary endothelium Proc. Natl. Acad. Sci. U. S. A. 93 11 1996 5213 5218
70. P.N. Reynolds, S.A. Nicklin, L. Kaliberova, B.G. Boatman, W.E. Grizzle, I.V. Balyasnikova, A.H. Baker, S.M. Danilov, and D.T. Curiel Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo Nat. Biotechnol. 19 9 2001 838 842
71. R. Langer Drug delivery and targeting Nature 392 6679 Suppl. 1998 5 10
72. V.S. Trubetskoy, V.P. Torchilin, S. Kennel, and L. Huang Cationic liposomes enhance targeted delivery and expression of exogenous DNA mediated by N-terminal modified poly(l-lysine)-antibody conjugate in mouse lung endothelial cells Biochim. Biophys. Acta 1131 3 1992 311 313
73. S.M. Danilov, A.V. Martynov, A.L. Klibanov, M.A. Slinkin, I. Sakharov, A.G. Malov, V.B. Sergienko, A. Vedernikov, V.R. Muzykantov, and V.P. Torchilin Radioimmunoimaging of lung vessels: an approach using indium-111-labeled monoclonal antibody to angiotensin-converting enzyme J. Nucl. Med. 30 10 1989 1686 1692
74. K. Maruyama, T. Takizawa, T. Yuda, S.J. Kennel, L. Huang, and M. Iwatsuru Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies Biochim. Biophys. Acta 1234 1 1995 74 80
75. A. Scherpereel, J.J. Rome, R. Wiewrodt, S.C. Watkins, D.W. Harshaw, S. Alder, M. Christofidou-Solomidou, E. Haut, J.C. Murciano, M. Nakada, S.M. Albelda, and V.R. Muzykantov Platelet-endothelial cell adhesion molecule-1-directed immunotargeting to cardiopulmonary vasculature J. Pharmacol. Exp. Ther. 300 3 2002 777 786
76. K. Danielyan, B.S. Ding, C. Gottstein, D.B. Cines, and V.R. Muzykantov Delivery of anti-platelet-endothelial cell adhesion molecule single-chain variable fragment-urokinase fusion protein to the cerebral vasculature lyses arterial clots and attenuates postischemic brain edema J. Pharmacol. Exp. Ther. 321 3 2007 947 952
77. E. Durr, J. Yu, K.M. Krasinska, L.A. Carver, J.R. Yates, J.E. Testa, P. Oh, and J.E. Schnitzer Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture Nat. Biotechnol. 22 8 2004 985 992
78. A. Tradonsky, T. Rubin, R. Beck, B. Ring, R. Seitz, and S. Mair A search for reliable molecular markers of prognosis in prostate cancer: a study of 240 cases Am. J. Clin. Pathol. 137 6 2012 918 930
79. K.C. Wood, S.M. Azarin, W. Arap, R. Pasqualini, R. Langer, and P.T. Hammond Tumor-targeted gene delivery using molecularly engineered hybrid polymers functionalized with a tumor-homing peptide Bioconjug. Chem. 19 2 2008 403 405
80. P. Valadon, J.D. Garnett, J.E. Testa, M. Bauerle, P. Oh, and J.E. Schnitzer Screening phage display libraries for organ-specific vascular immunotargeting in vivo Proc. Natl. Acad. Sci. U. S. A. 103 2 2006 407 412
81. M. Howard, B.J. Zern, A.C. Anselmo, V.V. Shuvaev, S. Mitragotri, and V. Muzykantov Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm ACS Nano 8 5 2014 4100 4132
82. C. Garnacho, S.M. Albelda, V.R. Muzykantov, and S. Muro Differential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopes J. Control. Release 130 3 2008 226 233
83. A.W. Mulivor, and H.H. Lipowsky Role of glycocalyx in leukocyte-endothelial cell adhesion Am. J. Physiol. Heart Circ. Physiol. 283 4 2002 H1282 H1291
84. V.R. Muzykantov, E.A. Puchnina, E.N. Atochina, H. Hiemish, M.A. Slinkin, F.E. Meertsuk, and S.M. Danilov Endotoxin reduces specific pulmonary uptake of radiolabeled monoclonal antibody to angiotensin-converting enzyme J. Nucl. Med. 32 3 1991 453 460
85. R.A. Skidgel Bradykinin-degrading enzymes: structure, function, distribution, and potential roles in cardiovascular pharmacology J. Cardiovasc. Pharmacol. 20 Suppl. 9 1992 S4 S9
86. W.C. Aird, J.M. Edelberg, H. Weiler-Guettler, W.W. Simmons, T.W. Smith, and R.D. Rosenberg Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment J. Cell Biol. 138 5 1997 1117 1124
87. W.C. Aird Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms Circ. Res. 100 2 2007 158 173
88. P.F. Davies Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology Nat. Clin. Pract. Cardiovasc. Med. 6 1 2009 16 26
89. B. Beneteau-Burnat, and B. Baudin Angiotensin-converting enzyme: clinical applications and laboratory investigations on serum and other biological fluids Crit. Rev. Clin. Lab. Sci. 28 5-6 1991 337 356
90. V.V. Shuvaev, M. Christofidou-Solomidou, A. Scherpereel, E. Simone, E. Arguiri, S. Tliba, J. Pick, S. Kennel, S.M. Albelda, and V.R. Muzykantov Factors modulating the delivery and effect of enzymatic cargo conjugated with antibodies targeted to the pulmonary endothelium J. Control. Release 118 2 2007 235 244
91. S.M. Danilov, V.D. Gavrilyuk, F.E. Franke, K. Pauls, D.W. Harshaw, T.D. McDonald, D.J. Miletich, and V.R. Muzykantov Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting Am. J. Physiol. Lung Cell. Mol. Physiol. 280 6 2001 L1335 L1347
92. E.T. Keelan, A.A. Harrison, P.T. Chapman, R.M. Binns, A.M. Peters, and D.O. Haskard Imaging vascular endothelial activation: an approach using radiolabeled monoclonal antibodies against the endothelial cell adhesion molecule E-selectin J. Nucl. Med. 35 2 1994 276 281
93. S. Muro, M. Koval, and V. Muzykantov Endothelial endocytic pathways: gates for vascular drug delivery Curr. Vasc. Pharmacol. 2 3 2004 281 299
94. P.J. Newman, and S.M. Albelda Cellular and molecular aspects of PECAM-1 Nouv. Rev. Fr. Hematol. 34 Suppl. 1992 S9 13
95. M. Giannotta, M. Trani, and E. Dejana VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity Dev. Cell 26 5 2013 441 454
96. O. Barreiro, M. Yanez-Mo, M. Sala-Valdes, M.D. Gutierrez-Lopez, S. Ovalle, A. Higginbottom, P.N. Monk, C. Cabanas, and F. Sanchez-Madrid Endothelial tetraspanin microdomains regulate leukocyte firm adhesion during extravasation Blood 105 7 2005 2852 2861
97. J.M. Cook-Mills, M.E. Marchese, and H. Abdala-Valencia Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants Antioxid. Redox Signal. 15 6 2011 1607 1638
98. A. Almenar-Queralt, A. Duperray, L.A. Miles, J. Felez, and D.C. Altieri Apical topography and modulation of ICAM-1 expression on activated endothelium Am. J. Pathol. 147 5 1995 1278 1288
99. M.D. Wright, G.W. Moseley, and A.B. van Spriel Tetraspanin microdomains in immune cell signalling and malignant disease Tissue Antigens 64 5 2004 533 542
100. L. Ghitescu, B.S. Jacobson, and P. Crine A novel, 85 kDa endothelial antigen differentiates plasma membrane macrodomains in lung alveolar capillaries Endothelium 6 3 1999 241 250
101. J.C. Murciano, D.W. Harshaw, L. Ghitescu, S.M. Danilov, and V.R. Muzykantov Vascular immunotargeting to endothelial surface in a specific macrodomain in alveolar capillaries Am. J. Respir. Crit. Care Med. 164 7 2001 1295 1302
102. P. Oh, P. Borgstrom, H. Witkiewicz, Y. Li, B.J. Borgstrom, A. Chrastina, K. Iwata, K.R. Zinn, R. Baldwin, J.E. Testa, and J.E. Schnitzer Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung Nat. Biotechnol. 25 3 2007 327 337
103. S. Danilov, E. Atochina, H. Hiemisch, T. Churak-ova, A. Moldobayeva, I. Sakharov, G. Deichman, U. Ryan, and V.R. Muzykantov Interaction of mAb to angiotensin-converting enzyme (ACE) with antigen in vitro and in vivo: antibody targeting to the lung induces ACE antigenic modulation Int. Immunol. 6 8 1994 1153 1160
104. S.J. Kennel, R. Falcioni, and J.W. Wesley Microdistribution of specific rat monoclonal antibodies to mouse tissues and human tumor xenografts Cancer Res. 51 5 1991 1529 1536
105. E.G. Erdos Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture Hypertension 16 4 1990 363 370
106. H. Heitsch, S. Brovkovych, T. Malinski, and G. Wiemer Angiotensin-(1-7)-stimulated nitric oxide and superoxide release from endothelial cells Hypertension 37 1 2001 72 76
107. I.V. Balyasnikova, E.H. Karran, R.F. Albrecht 2nd, and S.M. Danilov Epitope-specific antibody-induced cleavage of angiotensin-converting enzyme from the cell surface Biochem. J. 362 Pt 3 2002 585 595
108. V.R. Muzykantov V.R. Muzykantov, V.P. Torchilin, Biomedical Aspects of Drug Targeting 2002 Kluwer Academic Publishers Boston 129 148
109. V.R. Muzykantov Targeting of superoxide dismutase and catalase to vascular endothelium J. Control. Release 71 1 2001 1 21
110. K. Watanabe, G. Lam, R.S. Keresztes, and E.A. Jaffe Lipopolysaccharides decrease angiotensin converting enzyme activity expressed by cultured human endothelial cells J. Cell. Physiol. 150 2 1992 433 439
111. E.N. Atochina, H.H. Hiemisch, V.R. Muzykantov, and S.M. Danilov Systemic administration of platelet-activating factor in rat reduces specific pulmonary uptake of circulating monoclonal antibody to angiotensin-converting enzyme Lung 170 6 1992 349 358
112. I.V. Balyasnikova, Z.L. Sun, R. Metzger, P.R. Taylor, E. Vicini, B. Muciaccia, D.J. Visintine, Y.V. Berestetskaya, T.D. McDonald, and S.M. Danilov Monoclonal antibodies to native mouse angiotensin-converting enzyme (CD143): ACE expression quantification, lung endothelial cell targeting and gene delivery Tissue Antigens 67 1 2006 10 29
113. E.N. Atochina, V.R. Muzykantov, A.B. Al-Mehdi, S.M. Danilov, and A.B. Fisher Normoxic lung ischemia/reperfusion accelerates shedding of angiotensin converting enzyme from the pulmonary endothelium Am. J. Respir. Crit. Care Med. 156 4 Pt 1 1997 1114 1119
114. V.R. Muzykantov, E.N. Atochina, A. Kuo, E.S. Barnathan, K. Notarfrancesco, H. Shuman, C. Dodia, and A.B. Fisher Endothelial cells internalize monoclonal antibody to angiotensin-converting enzyme Am. J. Phys. 270 5 Pt 1 1996 L704 L713
115. I.V. Balyasnikova, R. Metzger, D.J. Visintine, V. Dimasius, Z.L. Sun, Y.V. Berestetskaya, T.D. McDonald, D.T. Curiel, R.D. Minshall, and S.M. Danilov Selective rat lung endothelial targeting with a new set of monoclonal antibodies to angiotensin I-converting enzyme Pulm. Pharmacol. Ther. 18 4 2005 251 267
116. P.N. Reynolds, K.R. Zinn, V.D. Gavrilyuk, I.V. Balyasnikova, B.E. Rogers, D.J. Buchsbaum, M.H. Wang, D.J. Miletich, W.E. Grizzle, J.T. Douglas, S.M. Danilov, and D.T. Curiel A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo Mol. Ther. 2 6 2000 562 578
117. W.H. Miller, M.J. Brosnan, D. Graham, C.G. Nicol, I. Morecroft, K.M. Channon, S.M. Danilov, P.N. Reynolds, A.H. Baker, and A.F. Dominiczak Targeting endothelial cells with adenovirus expressing nitric oxide synthase prevents elevation of blood pressure in stroke-prone spontaneously hypertensive rats Mol. Ther. 12 2 2005 321 327
118. A.M. Reynolds, W. Xia, M.D. Holmes, S.J. Hodge, S. Danilov, D.T. Curiel, N.W. Morrell, and P.N. Reynolds Bone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertension Am. J. Physiol. Lung Cell Mol. Physiol. 292 5 2007 L1182 L1192
119. F.A. Martin, R.P. Murphy, and P.M. Cummins Thrombomodulin and the vascular endothelium: insights into functional, regulatory, and therapeutic aspects Am. J. Physiol. Heart Circ. Physiol. 304 12 2013 H1585 H1597
120. M. Christofidou-Solomidou, S. Kennel, A. Scherpereel, R. Wiewrodt, C.C. Solomides, G.G. Pietra, J.C. Murciano, S.A. Shah, H. Ischiropoulos, S.M. Albelda, and V.R. Muzykantov Vascular immunotargeting of glucose oxidase to the endothelial antigens induces distinct forms of oxidant acute lung injury: targeting to thrombomodulin, but not to PECAM-1, causes pulmonary thrombosis and neutrophil transmigration Am. J. Pathol. 160 3 2002 1155 1169
121. S. Perkowski, J. Sun, S. Singhal, J. Santiago, G.D. Leikauf, and S.M. Albelda Gene expression profiling of the early pulmonary response to hyperoxia in mice Am. J. Respir. Cell Mol. Biol. 28 6 2003 682 696
122. C. Brisson, G. Archipoff, M.L. Hartmann, D. Hanau, A. Beretz, J.M. Freyssinet, and J.P. Cazenave Antibodies to thrombomodulin induce receptor-mediated endocytosis in human saphenous vein endothelial cells Thromb. Haemost. 68 6 1992 737 743
123. S. Guermazi, F. Mellouli, S. Trabelsi, M. Bejaoui, and K. Dellagi Anti-thrombomodulin antibodies and venous thrombosis Blood Coagul. Fibrinolysis 15 7 2004 553 558
124. R.G. Parton, and K. Simons The multiple faces of caveolae Nat. Rev. Mol. Cell Biol. 8 3 2007 185 194
125. H. Riezman, P.G. Woodman, G. van Meer, and M. Marsh Molecular mechanisms of endocytosis Cell 91 6 1997 731 738
126. D. Predescu, and G.E. Palade Plasmalemmal vesicles represent the large pore system of continuous microvascular endothelium Am. J. Phys. 265 2 Pt 2 1993 H725 H733
127. R.V. Stan Structure and function of endothelial caveolae Microsc. Res. Tech. 57 5 2002 350 364
128. R.D. Minshall, C. Tiruppathi, S.M. Vogel, and A.B. Malik Vesicle formation and trafficking in endothelial cells and regulation of endothelial barrier function Histochem. Cell Biol. 117 2 2002 105 112
129. J.E. Schnitzer Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo Adv. Drug Deliv. Rev. 49 3 2001 265 280
130. J.E. Schnitzer, D.P. McIntosh, A.M. Dvorak, J. Liu, and P. Oh Separation of caveolae from associated microdomains of GPI-anchored proteins Science 269 5229 1995 1435 1439
131. R.D. Minshall, C. Tiruppathi, S.M. Vogel, W.D. Niles, A. Gilchrist, H.E. Hamm, and A.B. Malik Endothelial cell-surface gp60 activates vesicle formation and trafficking via G(i)-coupled Src kinase signaling pathway J. Cell Biol. 150 5 2000 1057 1070
132. S.M. Vogel, C.R. Easington, R.D. Minshall, W.D. Niles, C. Tiruppathi, S.M. Hollenberg, J.E. Parrillo, and A.B. Malik Evidence of transcellular permeability pathway in microvessels Microvasc. Res. 61 1 2001 87 101
133. T.A. John, S.M. Vogel, C. Tiruppathi, A.B. Malik, and R.D. Minshall Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer Am. J. Physiol. Lung Cell Mol. Physiol. 284 1 2003 L187 L196
134. C. Tiruppathi, W. Song, M. Bergenfeldt, P. Sass, and A.B. Malik Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway J. Biol. Chem. 272 41 1997 25968 25975
135. D. Predescu, S. Predescu, and A.B. Malik Transport of nitrated albumin across continuous vascular endothelium Proc. Natl. Acad. Sci. U. S. A. 99 21 2002 13932 13937
136. E.A. Simone, B.J. Zern, A.M. Chacko, J.L. Mikitsh, E.R. Blankemeyer, S. Muro, R.V. Stan, and V.R. Muzykantov Endothelial targeting of polymeric nanoparticles stably labeled with the PET imaging radioisotope iodine-124 Biomaterials 33 21 2012 5406 5413
137. T.G. Iversen, N. Frerker, and K. Sandvig Uptake of ricinB-quantum dot nanoparticles by a macropinocytosis-like mechanism J. Nanobiotechnol. 10 2012 33
138. Z. Wang, C. Tiruppathi, R.D. Minshall, and A.B. Malik Size and dynamics of caveolae studied using nanoparticles in living endothelial cells ACS Nano 3 12 2009 4110 4116
139. T.A. Springer Adhesion receptors of the immune system Nature 346 6283 1990 425 434
140. C.M. Doerschuk, W.M. Quinlan, N.A. Doyle, D.C. Bullard, D. Vestweber, M.L. Jones, F. Takei, P.A. Ward, and A.L. Beaudet The role of P-selectin and ICAM-1 in acute lung injury as determined using blocking antibodies and mutant mice J. Immunol. 157 10 1996 4609 4614
141. T.K. Kishimoto, and R. Rothlein Integrins, ICAMs, and selectins: role and regulation of adhesion molecules in neutrophil recruitment to inflammatory sites Adv. Pharmacol. 25 1994 117 169
142. S.M. Albelda Endothelial and epithelial cell adhesion molecules Am. J. Respir. Cell Mol. Biol. 4 3 1991 195 203
143. A. Tsourkas, V.R. Shinde-Patil, K. Kelly, P. Patel, A. Wolley, J.R. Allport, and R. Weissleder In Vivo Imaging of Activated Endothelium Using an Anti-VCAM-1 Magneto-Optical Probe 2005
144. J.M. Kiely, M.I. Cybulsky, F.W. Luscinskas, and M.A. Gimbrone Jr. Immunoselective targeting of an anti-thrombin agent to the surface of cytokine-activated vascular endothelial cells Arterioscler. Thromb. Vasc. Biol. 15 8 1995 1211 1218
145. T.W. Kuijpers, M. Raleigh, T. Kavanagh, H. Janssen, J. Calafat, D. Roos, and J.M. Harlan Cytokine-activated endothelial cells internalize E-selectin into a lysosomal compartment of vesiculotubular shape. A tubulin-driven process J. Immunol. 152 10 1994 5060 5069
146. K.S. Straley, S.A. Green, Rapid transport of internalized P-selectin to late endosomes and the TGN: roles in regulating cell surface expression and recycling to secretory granules. J. Cell Biol. 151(1) (2000) 107-116.
147. E.J. von Asmuth, E.F. Smeets, L.A. Ginsel, J.J. Onderwater, J.F. Leeuwenberg, and W.A. Buurman Evidence for endocytosis of E-selectin in human endothelial cells Eur. J. Immunol. 22 10 1992 2519 2526
148. S. Kessner, A. Krause, U. Rothe, and G. Bendas Investigation of the cellular uptake of E-selectin-targeted immunoliposomes by activated human endothelial cells Biochim. Biophys. Acta 1514 2 2001 177 190
149. M. Everts, R.J. Kok, S.A. Asgeirsdottir, B.N. Melgert, T.J. Moolenaar, G.A. Koning, M.J. van Luyn, D.K. Meijer, and G. Molema Selective intracellular delivery of dexamethasone into activated endothelial cells using an E-selectin-directed immunoconjugate J. Immunol. 168 2 2002 883 889
150. O.A. Harari, T.J. Wickham, C.J. Stocker, I. Kovesdi, D.M. Segal, T.Y. Huehns, C. Sarraf, and D.O. Haskard Targeting an adenoviral gene vector to cytokine-activated vascular endothelium via E-selectin Gene Ther. 6 5 1999 801 807
151. J.R. Lindner, J. Song, J. Christiansen, A.L. Klibanov, F. Xu, and K. Ley Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin Circulation 104 17 2001 2107 2112
152. J.R. Lindner, A.L. Klibanov, and K. Ley V.R. Muzykantov, V.P. Torchilin, Biomedical Aspects of Drug Targeting 2003 Kluwer Academic Pub Boston 149 172
153. G.A. Koning, R.M. Schiffelers, and G. Storm Endothelial cells at inflammatory sites as target for therapeutic intervention Endothelium 9 3 2002 161 171
154. S. Muro, C. Gajewski, M. Koval, and V.R. Muzykantov ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs Blood 105 2 2005 650 658
155. B.S. Ding, T. Dziubla, V.V. Shuvaev, S. Muro, and V.R. Muzykantov Advanced drug delivery systems that target the vascular endothelium Mol. Interv. 6 2 2006 98 112
156. S. Muro, R. Wiewrodt, A. Thomas, L. Koniaris, S.M. Albelda, V.R. Muzykantov, and M. Koval A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1 J. Cell Sci. 116 Pt 8 2003 1599 1609
157. A. Omolola Eniola, and D.A. Hammer In vitro characterization of leukocyte mimetic for targeting therapeutics to the endothelium using two receptors Biomaterials 26 34 2005 7136 7144
158. R.C. Gunawan, and D.T. Auguste The role of antibody synergy and membrane fluidity in the vascular targeting of immunoliposomes Biomaterials 31 5 2010 900 907
159. D. Sun, S. Nakao, F. Xie, S. Zandi, A. Schering, and A. Hafezi-Moghadam Superior sensitivity of novel molecular imaging probe: simultaneously targeting two types of endothelial injury markers FASEB J. 24 5 2010 1532 1540
160. A.O. Eniola, P.J. Willcox, and D.A. Hammer Interplay between rolling and firm adhesion elucidated with a cell-free system engineered with two distinct receptor-ligand pairs Biophys. J. 85 4 2003 2720 2731
161. R.C. Gunawan, and D.T. Auguste Immunoliposomes that target endothelium in vitro are dependent on lipid raft formation Mol. Pharm. 7 5 2010 1569 1575
162. R.C. Gunawan, D. Almeda, and D.T. Auguste Complementary targeting of liposomes to IL-1alpha and TNF-alpha activated endothelial cells via the transient expression of VCAM1 and E-selectin Biomaterials 32 36 2011 9848 9853
163. M.A. McAteer, J.E. Schneider, Z.A. Ali, N. Warrick, C.A. Bursill, C. Von zur Muhlen, D.R. Greaves, S. Neubauer, K.M. Channon, and R.P. Choudhury Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide Arterioscler. Thromb. Vasc. Biol. 28 1 2008 77 83
164. G.E. Weller, F.S. Villanueva, E.M. Tom, and W.R. Wagner Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewisx Biotechnol. Bioeng. 92 6 2005 780 788
165. I.T. Papademetriou, C. Garnacho, E.H. Schuchman, and S. Muro In vivo performance of polymer nanocarriers dually-targeted to epitopes of the same or different receptors Biomaterials 34 13 2013 3459 3466
166. S. Danilov, E. Jaspard, T. Churakova, H. Towbin, F. Savoie, L. Wei, and F. Alhenc-Gelas Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. Selective inhibition of the amino-terminal active site J. Biol. Chem. 269 43 1994 26806 26814
167. K. Gordon, I.V. Balyasnikova, A.B. Nesterovitch, D.E. Schwartz, E.D. Sturrock, and S.M. Danilov Fine epitope mapping of monoclonal antibodies 9B9 and 3G8 to the N domain of angiotensin-converting enzyme (CD143) defines a region involved in regulating angiotensin-converting enzyme dimerization and shedding Tissue Antigens 75 2 2010 136 150
168. A.M. Chacko, M. Nayak, C.F. Greineder, H.M. Delisser, and V.R. Muzykantov Collaborative enhancement of antibody binding to distinct PECAM-1 epitopes modulates endothelial targeting PLoS One 7 4 2012 e34958
169. D.R. Elias, A. Poloukhtine, V. Popik, and A. Tsourkas Effect of ligand density, receptor density, and nanoparticle size on cell targeting Nanomedicine 9 2 2013 194 201
170. A. Fakhari, A. Baoum, T.J. Siahaan, K.B. Le, and C. Berkland Controlling ligand surface density optimizes nanoparticle binding to ICAM-1 J. Pharm. Sci. 100 3 2011 1045 1056
171. F. Gu, L. Zhang, B.A. Teply, N. Mann, A. Wang, A.F. Radovic-Moreno, R. Langer, and O.C. Farokhzad Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers Proc. Natl. Acad. Sci. U. S. A. 105 7 2008 2586 2591
172. B.J. Zern, A.-M. Chacko, J. Liu, C.F. Greineder, E.R. Blankemeyer, R. Radhakrishnan, and V. Muzykantov Reduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammation ACS Nano 7 3 2013 2461 2469
173. J.L. Perry, M.P. Kai, K.G. Reuter, C. Bowerman, J. Christopher Luft, and J.M. DeSimone Calibration-quality cancer nanotherapeutics Cancer Treat. Res. 166 2015 275 291
174. J.D. Pillai, S.S. Dunn, M.E. Napier, and J.M. DeSimone Novel platforms for vascular carriers with controlled geometry IUBMB Life 63 8 2011 596 606
175. A.C. Anselmo, M. Zhang, S. Kumar, D.R. Vogus, S. Menegatti, M.E. Helgeson, and S. Mitragotri Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting ACS Nano 9 3 2015 3169 3177
176. N.S. Oltra, P. Nair, and D.E. Discher From stealthy polymersomes and filomicelles to "self" peptide-nanoparticles for cancer therapy Annu. Rev. Chem. Biomol. Eng. 5 2014 281 299
177. A. Mahmud, and D.E. Discher Lung vascular targeting through inhalation delivery: insight from filamentous viruses and other shapes IUBMB Life 63 8 2011 607 612
178. S. Mitragotri, and J. Lahann Materials for drug delivery: innovative solutions to address complex biological hurdles Adv. Mater. 24 28 2012 3717 3723
179. K.G. Reuter, J. Perry, D. Kim, J.C. Luft, R. Liu, and J.M. DeSimone Targeted PRINT hydrogels: the role of nanoparticle size and ligand density on cell association, biodistribution, and tumor accumulation Nano Lett. 2015
180. R.A. Roberts, T.K. Eitas, J.D. Byrne, B.M. Johnson, P.J. Short, K.P. McKinnon, S. Reisdorf, J.C. Luft, J.M. DeSimone, and J.P. Ting Towards programming immune tolerance through geometric manipulation of phosphatidylserine Biomaterials 72 2015 1 10
181. D. Ma, S. Tian, J. Baryza, J.C. Luft, and J.M. DeSimone Reductively responsive hydrogel nanoparticles with uniform size, shape, and tunable composition for systemic siRNA delivery in vivo Mol. Pharm. 2015
182. P. Decuzzi, R. Pasqualini, W. Arap, and M. Ferrari Intravascular delivery of particulate systems: does geometry really matter? Pharm. Res. 26 1 2009 235 243
183. A.C. Anselmo, and S. Mitragotri Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles J. Control. Release 190 2014 531 541
184. S. Muro, C. Garnacho, J.A. Champion, J. Leferovich, C. Gajewski, E.H. Schuchman, S. Mitragotri, and V.R. Muzykantov Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers Mol. Ther. 16 8 2008 1450 1458
185. V.V. Shuvaev, S. Tliba, J. Pick, E. Arguiri, M. Christofidou-Solomidou, S.M. Albelda, and V.R. Muzykantov Modulation of endothelial targeting by size of antibody-antioxidant enzyme conjugates J. Control. Release 149 3 2011 236 241
186. P. Kolhar, A.C. Anselmo, V. Gupta, K. Pant, B. Prabhakarpandian, E. Ruoslahti, and S. Mitragotri Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium Proc. Natl. Acad. Sci. U. S. A. 110 26 2013 10753 10758
187. V.V. Shuvaev, M.A. Ilies, E. Simone, S. Zaitsev, Y. Kim, S. Cai, A. Mahmud, T. Dziubla, S. Muro, D.E. Discher, and V.R. Muzykantov Endothelial targeting of antibody-decorated polymeric filomicelles ACS Nano 5 9 2011 6991 6999
188. I. Ricard, M.D. Payet, and G. Dupuis VCAM-1 is internalized by a clathrin-related pathway in human endothelial cells but its alpha 4 beta 1 integrin counter-receptor remains associated with the plasma membrane in human T lymphocytes Eur. J. Immunol. 28 5 1998 1708 1718
189. H.S. Sakhalkar, M.K. Dalal, A.K. Salem, R. Ansari, J. Fu, M.F. Kiani, D.T. Kurjiaka, J. Hanes, K.M. Shakesheff, and D.J. Goetz Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo Proc. Natl. Acad. Sci. U. S. A. 100 26 2003 15895 15900
190. A. Tsourkas, V.R. Shinde-Patil, K.A. Kelly, P. Patel, A. Wolley, J.R. Allport, and R. Weissleder In vivo imaging of activated endothelium using an anti-VCAM-1 magnetooptical probe Bioconjug. Chem. 16 3 2005 576 581
191. K.A. Kelly, J.R. Allport, A. Tsourkas, V.R. Shinde-Patil, L. Josephson, and R. Weissleder Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle Circ. Res. 96 3 2005 327 336
192. W.M. Pardridge Blood-brain barrier drug targeting: the future of brain drug development Mol. Interv. 3 2 2003 90 105 151
193. M. Christofidou-Solomidou, and V.R. Muzykantov Antioxidant strategies in respiratory medicine Treat. Respir. Med. 5 1 2006 47 78
194. R. Pasqualini, W. Arap, and D.M. McDonald Probing the structural and molecular diversity of tumor vasculature Trends Mol. Med. 8 12 2002 563 571
195. E. Tagliabue, F. Centis, M. Campiglio, A. Mastroianni, S. Martignone, R. Pellegrini, P. Casalini, C. Lanzi, S. Menard, and M.I. Colnaghi Selection of monoclonal antibodies which induce internalization and phosphorylation of p185HER2 and growth inhibition of cells with HER2/NEU gene amplification Int. J. Cancer 47 6 1991 933 937
196. W.G. Feero, S. Li, J.D. Rosenblatt, N. Sirianni, J.E. Morgan, T.A. Partridge, L. Huang, and E.P. Hoffman Selection and use of ligands for receptor-mediated gene delivery to myogenic cells Gene Ther. 4 7 1997 664 674
197. Y. Zhou, L. Zhao, and J.D. Marks Selection and characterization of cell binding and internalizing phage antibodies Arch. Biochem. Biophys. 526 2 2012 107 113
198. Y. Zhou, H. Zou, S. Zhang, and J.D. Marks Internalizing cancer antibodies from phage libraries selected on tumor cells and yeast-displayed tumor antigens J. Mol. Biol. 404 1 2010 88 99
199. T. Heitner, A. Moor, J.L. Garrison, C. Marks, T. Hasan, and J.D. Marks Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library J. Immunol. Methods 248 1-2 2001 17 30
200. S. Muro Challenges in design and characterization of ligand-targeted drug delivery systems J. Control. Release 164 2 2012 125 137
201. L.A. Carver, and J.E. Schnitzer Caveolae: mining little caves for new cancer targets Nat. Rev. Cancer 3 8 2003 571 581
202. S. Muro, X. Cui, C. Gajewski, J.C. Murciano, V.R. Muzykantov, and M. Koval Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress Am. J. Physiol. Cell Physiol. 285 5 2003 C1339 C1347
203. S. Muro, E.H. Schuchman, and V.R. Muzykantov Lysosomal enzyme delivery by ICAM-1-targeted nanocarriers bypassing glycosylation- and clathrin-dependent endocytosis Mol. Ther. 13 1 2006 135 141
204. T. Bhowmick, E. Berk, X. Cui, V.R. Muzykantov, and S. Muro Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1 J. Control. Release 157 3 2012 485 492
205. S.P. Samuel, N. Jain, F. O'Dowd, T. Paul, D. Kashanin, V.A. Gerard, Y.K. Gun'ko, A. Prina-Mello, and Y. Volkov Multifactorial determinants that govern nanoparticle uptake by human endothelial cells under flow Int. J. Nanomedicine 7 2012 2943 2956
206. A.D. Terrisse, N. Puech, S. Allart, P. Gourdy, J.M. Xuereb, B. Payrastre, and P. Sie Internalization of microparticles by endothelial cells promotes platelet/endothelial cell interaction under flow J. Thromb. Haemost. 8 12 2010 2810 2819
207. J. Han, B.J. Zern, V.V. Shuvaev, P.F. Davies, S. Muro, and V. Muzykantov Acute and chronic shear stress differently regulate endothelial internalization of nanocarriers targeted to platelet-endothelial cell adhesion molecule-1 ACS Nano 6 10 2012 8824 8836
208. D. Serrano, T. Bhowmick, R. Chadha, C. Garnacho, and S. Muro Intercellular adhesion molecule 1 engagement modulates sphingomyelinase and ceramide, supporting uptake of drug carriers by the vascular endothelium Arterioscler. Thromb. Vasc. Biol. 32 5 2012 1178 1185
209. C. Garnacho, R. Dhami, E. Simone, T. Dziubla, J. Leferovich, E.H. Schuchman, V. Muzykantov, and S. Muro Delivery of acid sphingomyelinase in normal and Niemann-Pick disease mice using intercellular adhesion molecule-1-targeted polymer nanocarriers J. Pharmacol. Exp. Ther. 325 2 2008 400 408
210. M. Ansar, D. Serrano, I. Papademetriou, T.K. Bhowmick, and S. Muro Biological functionalization of drug delivery carriers to bypass size restrictions of receptor-mediated endocytosis independently from receptor targeting ACS Nano 7 12 2013 10597 10611
211. Y. Zhang, F. Schlachetzki, and W.M. Pardridge Global non-viral gene transfer to the primate brain following intravenous administration Mol. Ther. 7 1 2003 11 18
212. J.E. Schnitzer, P. Oh, and D.P. McIntosh Role of GTP hydrolysis in fission of caveolae directly from plasma membranes Science 274 5285 1996 239 242
213. A.M. Dvorak, and D. Feng The vesiculo-vacuolar organelle (VVO). A new endothelial cell permeability organelle J. Histochem. Cytochem. 49 4 2001 419 432
214. J.E. Schnitzer, J. Liu, and P. Oh Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases J. Biol. Chem. 270 24 1995 14399 14404
215. E. Dejana Endothelial adherens junctions: implications in the control of vascular permeability and angiogenesis J. Clin. Invest. 98 9 1996 1949 1953
216. D. Mehta, J. Bhattacharya, M.A. Matthay, and A.B. Malik Integrated control of lung fluid balance Am. J. Physiol. Lung Cell Mol. Physiol. 287 6 2004 L1081 L1090
217. W.M. Pardridge, J. Buciak, J. Yang, and D. Wu Enhanced endocytosis in cultured human breast carcinoma cells and in vivo biodistribution in rats of a humanized monoclonal antibody after cationization of the protein J. Pharmacol. Exp. Ther. 286 1 1998 548 554
218. D. Predescu, S.M. Vogel, and A.B. Malik Functional and morphological studies of protein transcytosis in continuous endothelia Am. J. Physiol. Lung Cell Mol. Physiol. 287 5 2004 L895 L901
219. R. Ghaffarian, T. Bhowmick, and S. Muro Transport of nanocarriers across gastrointestinal epithelial cells by a new transcellular route induced by targeting ICAM-1 J. Control. Release 163 1 2012 25 33
220. V. Mane, and S. Muro Biodistribution and endocytosis of ICAM-1-targeting antibodies versus nanocarriers in the gastrointestinal tract in mice Int. J. Nanomedicine 7 2012 4223 4237
221. D.G. Harrison, M.C. Gongora, T.J. Guzik, and J. Widder Oxidative stress and hypertension J. Am. Soc. Hypertens. 1 1 2007 30 44
222. E. Schulz, T. Gori, and T. Munzel Oxidative stress and endothelial dysfunction in hypertension Hypertens. Res. 34 6 2011 665 673
223. Q. Li, N.Y. Spencer, F.D. Oakley, G.R. Buettner, and J.F. Engelhardt Endosomal Nox2 facilitates redox-dependent induction of NF-kappaB by TNF-alpha Antioxid. Redox Signal. 11 6 2009 1249 1263
224. P. Lajoie, J.G. Goetz, J.W. Dennis, and I.R. Nabi Lattices, rafts, and scaffolds: domain regulation of receptor signaling at the plasma membrane J. Cell Biol. 185 3 2009 381 385
225. M. Ushio-Fukai Compartmentalization of redox signaling through NADPH oxidase-derived ROS Antioxid. Redox Signal. 11 6 2009 1289 1299
226. F.D. Oakley, D. Abbott, Q. Li, and J. Engelhardt Signaling components of redox active endosomes: the redoxosomes Antioxid. Redox Signal. 11 6 2009 1313 1333
227. V.V. Shuvaev, J. Han, K.J. Yu, S. Huang, B.J. Hawkins, M. Madesh, M. Nakada, and V.R. Muzykantov PECAM-targeted delivery of SOD inhibits endothelial inflammatory response FASEB J. 25 1 2011 348 357
228. V.R. Muzykantov Delivery of antioxidant enzyme proteins to the lung Antioxid. Redox Signal. 3 1 2001 39 62
229. M. Machtay, A. Scherpereel, J. Santiago, J. Lee, J. McDonough, P. Kinniry, E. Arguiri, V.V. Shuvaev, J. Sun, K. Cengel, C.C. Solomides, and M. Christofidou-Solomidou Systemic polyethylene glycol-modified (PEGylated) superoxide dismutase and catalase mixture attenuates radiation pulmonary fibrosis in the C57/bl6 mouse Radiother. Oncol. 81 2 2006 196 205
230. X. Yi, M.C. Zimmerman, R. Yang, J. Tong, S. Vinogradov, and A.V. Kabanov Pluronic-modified superoxide dismutase 1 attenuates angiotensin II-induced increase in intracellular superoxide in neurons Free Radic. Biol. Med. 49 4 2010 548 558
231. S. Lee, S.C. Yang, M.J. Heffernan, W.R. Taylor, and N. Murthy Polyketal microparticles: a new delivery vehicle for superoxide dismutase Bioconjug. Chem. 18 1 2007 4 7
232. M.K. Reddy, and V. Labhasetwar Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury FASEB J. 23 5 2009 1384 1395
233. E.G. Rosenbaugh, J.W. Roat, L. Gao, R.F. Yang, D.S. Manickam, J.X. Yin, H.D. Schultz, T.K. Bronich, E.V. Batrakova, A.V. Kabanov, I.H. Zucker, and M.C. Zimmerman The attenuation of central angiotensin II-dependent pressor response and intra-neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase Biomaterials 31 19 2010 5218 5226
234. J. Wen, X. Jiang, Y. Dai, Y. Zhang, Y. Tang, H. Sun, T. Mi, R.E. Kellems, M.R. Blackburn, and Y. Xia Adenosine deaminase enzyme therapy prevents and reverses the heightened cavernosal relaxation in priapism J. Sex Med. 7 9 2009 3011 3022
235. M.W. Epperly, H.L. Guo, M. Jefferson, S. Nie, J. Gretton, M. Bernarding, D. Bar-Sagi, H. Archer, and J.S. Greenberger Cell phenotype specific kinetics of expression of intratracheally injected manganese superoxide dismutase-plasmid/liposomes (MnSOD-PL) during lung radioprotective gene therapy Gene Ther. 10 2 2003 163 171
236. B. Gao, S.C. Flores, J.A. Leff, S.K. Bose, and J.M. McCord Synthesis and anti-inflammatory activity of a chimeric recombinant superoxide dismutase: SOD2/3 Am. J. Physiol. Lung Cell Mol. Physiol. 284 6 2003 L917 L925
237. T. Matsui, S. Yamagishi, K. Nakamura, and H. Inoue Bay w 9798, a dihydropyridine structurally related to nifedipine with no calcium channel-blocking properties, inhibits tumour necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in endothelial cells by suppressing reactive oxygen species generation J. Int. Med. Res. 35 6 2007 886 891
238. R. Igarashi, J. Hoshino, A. Ochiai, Y. Morizawa, and Y. Mizushima Lecithinized superoxide dismutase enhances its pharmacologic potency by increasing its cell membrane affinity J. Pharmacol. Exp. Ther. 271 3 1994 1672 1677
239. D.D. Koo, K.I. Welsh, N.E. West, K.M. Channon, A.J. Penington, J.A. Roake, P.J. Morris, and S.V. Fuggle Endothelial cell protection against ischemia/reperfusion injury by lecithinized superoxide dismutase Kidney Int. 60 2 2001 786 796
240. T. Ishihara, K. Tanaka, Y. Tasaka, T. Namba, J. Suzuki, S. Okamoto, T. Hibi, M. Takenaga, R. Igarashi, K. Sato, Y. Mizushima, and T. Mizushima Therapeutic effect of lecithinized superoxide dismutase against colitis J. Pharmacol. Exp. Ther. 328 1 2009 152 164
241. V.E. Kagan, P. Wipf, D. Stoyanovsky, J.S. Greenberger, G. Borisenko, N.A. Belikova, N. Yanamala, A.K. Samhan Arias, M.A. Tungekar, J. Jiang, Y.Y. Tyurina, J. Ji, J. Klein-Seetharaman, B.R. Pitt, A.A. Shvedova, and H. Bayir Mitochondrial targeting of electron scavenging antioxidants: regulation of selective oxidation vs random chain reactions Adv. Drug Deliv. Rev. 61 14 2009 1375 1385
242. M.W. Epperly, C.A. Sikora, S.J. DeFilippi, J.E. Gretton, D. Bar-Sagi, H. Archer, T. Carlos, H. Guo, and J.S. Greenberger Pulmonary irradiation-induced expression of VCAM-I and ICAM-I is decreased by manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) gene therapy Biol. Blood Marrow Transplant. 8 4 2002 175 187
243. G.S. Supinski, and L.A. Callahan Polyethylene glycol-superoxide dismutase prevents endotoxin-induced cardiac dysfunction Am. J. Respir. Crit. Care Med. 173 11 2006 1240 1247
244. D. Hernandez-Saavedra, H. Zhou, and J.M. McCord Anti-inflammatory properties of a chimeric recombinant superoxide dismutase: SOD2/3 Biomed. Pharmacother. 59 4 2005 204 208
245. L.Y. Chang, M. Subramaniam, B.A. Yoder, B.J. Day, M.C. Ellison, M.E. Sunday, and J.D. Crapo A catalytic antioxidant attenuates alveolar structural remodeling in bronchopulmonary dysplasia Am. J. Respir. Crit. Care Med. 167 1 2003 57 64
246. Z. Vujaskovic, I. Batinic-Haberle, Z.N. Rabbani, Q.F. Feng, S.K. Kang, I. Spasojevic, T.V. Samulski, I. Fridovich, M.W. Dewhirst, and M.S. Anscher A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase (SOD) mimetic properties protects lungs from radiation-induced injury Free Radic. Biol. Med. 33 6 2002 857 863
247. C.S. Bonder, D. Knight, D. Hernandez-Saavedra, J.M. McCord, and P. Kubes Chimeric SOD2/3 inhibits at the endothelial-neutrophil interface to limit vascular dysfunction in ischemia-reperfusion Am. J. Physiol. Gastrointest. Liver Physiol. 287 3 2004 G676 G684
248. C. Danel, S.C. Erzurum, P. Prayssac, N.T. Eissa, R.G. Crystal, P. Herve, B. Baudet, M. Mazmanian, and P. Lemarchand Gene therapy for oxidant injury-related diseases: adenovirus-mediated transfer of superoxide dismutase and catalase cDNAs protects against hyperoxia but not against ischemia-reperfusion lung injury Hum. Gene Ther. 9 10 1998 1487 1496
249. R.J. Folz, A.M. Abushamaa, and H.B. Suliman Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia J. Clin. Invest. 103 7 1999 1055 1066
250. J. Jiang, I. Kurnikov, N.A. Belikova, J. Xiao, Q. Zhao, A.A. Amoscato, R. Braslau, A. Studer, M.P. Fink, J.S. Greenberger, P. Wipf, and V.E. Kagan Structural requirements for optimized delivery, inhibition of oxidative stress, and antiapoptotic activity of targeted nitroxides J. Pharmacol. Exp. Ther. 320 3 2007 1050 1060
251. V.R. Muzykantov, M. Christofidou-Solomidou, I. Balyasnikova, D.W. Harshaw, L. Schultz, A.B. Fisher, and S.M. Albelda Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs Proc. Natl. Acad. Sci. U. S. A. 96 5 1999 2379 2384
252. V.V. Shuvaev, S. Tliba, M. Nakada, S.M. Albelda, and V.R. Muzykantov Platelet-endothelial cell adhesion molecule-1-directed endothelial targeting of superoxide dismutase alleviates oxidative stress caused by either extracellular or intracellular superoxide J. Pharmacol. Exp. Ther. 323 2 2007 450 457
253. V.R. Muzykantov, D.V. Sakharov, S.P. Domogatsky, N.V. Goncharov, and S.M. Danilov Directed targeting of immunoerythrocytes provides local protection of endothelial cells from damage by hydrogen peroxide Am. J. Pathol. 128 2 1987 276 285
254. D.V. Sakharov, V.R. Muzykantov, S.P. Domogatsky, and S.M. Danilov Protection of cultured endothelial cells from hydrogen peroxide-induced injury by antibody-conjugated catalase Biochim. Biophys. Acta 930 2 1987 140 144
255. T.D. Sweitzer, A.P. Thomas, R. Wiewrodt, M.T. Nakada, F. Branco, and V.R. Muzykantov PECAM-directed immunotargeting of catalase: specific, rapid and transient protection against hydrogen peroxide Free Radic. Biol. Med. 34 8 2003 1035 1046
256. E.N. Atochina, I.V. Balyasnikova, S.M. Danilov, D.N. Granger, A.B. Fisher, and V.R. Muzykantov Immunotargeting of catalase to ACE or ICAM-1 protects perfused rat lungs against oxidative stress Am. J. Phys. 275 4 Pt 1 1998 L806 L817
257. A. Scherpereel, R. Wiewrodt, M. Christofidou-Solomidou, R. Gervais, J.C. Murciano, S.M. Albelda, and V.R. Muzykantov Cell-selective intracellular delivery of a foreign enzyme to endothelium in vivo using vascular immunotargeting FASEB J. 15 2 2001 416 426
258. B.D. Kozower, M. Christofidou-Solomidou, T.D. Sweitzer, S. Muro, D.G. Buerk, C.C. Solomides, S.M. Albelda, G.A. Patterson, and V.R. Muzykantov Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury Nat. Biotechnol. 21 4 2003 392 398
259. V.V. Shuvaev, M. Christofidou-Solomidou, F. Bhora, K. Laude, H. Cai, S. Dikalov, E. Arguiri, C.C. Solomides, S.M. Albelda, D.G. Harrison, and V.R. Muzykantov Targeted detoxification of selected reactive oxygen species in the vascular endothelium J. Pharmacol. Exp. Ther. 331 2 2009 404 411
260. K. Nowak, H.C. Kolbel, R.P. Metzger, C. Hanusch, M. Frohnmeyer, P. Hohenberger, and S.M. Danilov Immunotargeting of the pulmonary endothelium via angiotensin-converting-enzyme in isolated ventilated and perfused human lung Adv. Exp. Med. Biol. 756 2013 203 212
261. I. Morecroft, K. White, P. Caruso, M. Nilsen, L. Loughlin, R. Alba, P.N. Reynolds, S.M. Danilov, A.H. Baker, and M.R. Maclean Gene therapy by targeted adenovirus-mediated knockdown of pulmonary endothelial Tph1 attenuates hypoxia-induced pulmonary hypertension Mol. Ther. 20 8 2012 1516 1528
262. K. Nowak, C. Hanusch, K. Nicksch, R.P. Metzger, G. Beck, M.M. Gebhard, P. Hohenberger, and S.M. Danilov Pre-ischaemic conditioning of the pulmonary endothelium by immunotargeting of catalase via angiotensin-converting-enzyme antibodies Eur. J. Cardiothorac. Surg. 37 4 2010 859 863
263. K. Nowak, S. Weih, R. Metzger, R.F. Albrecht 2nd, S. Post, P. Hohenberger, M.M. Gebhard, and S.M. Danilov Immunotargeting of catalase to lung endothelium via anti-angiotensin-converting enzyme antibodies attenuates ischemia-reperfusion injury of the lung in vivo Am. J. Physiol. Lung Cell Mol. Physiol. 293 1 2007 L162 L169
264. V.V. Shuvaev, and V.R. Muzykantov Targeted modulation of reactive oxygen species in the vascular endothelium J. Control. Release 153 1 2011 56 63
265. M.D. Howard, C.F. Greineder, E.D. Hood, and V.R. Muzykantov Endothelial targeting of liposomes encapsulating SOD/catalase mimetic EUK-134 alleviates acute pulmonary inflammation J. Control. Release 177C 2014 34 41
266. J. Han, V.V. Shuvaev, and V.R. Muzykantov Catalase and superoxide dismutase conjugated with platelet-endothelial cell adhesion molecule antibody distinctly alleviate abnormal endothelial permeability caused by exogenous reactive oxygen species and vascular endothelial growth factor J. Pharmacol. Exp. Ther. 338 1 2011 82 91
267. V.V. Shuvaev, J. Han, S. Tliba, E. Arguiri, M. Christofidou-Solomidou, S.H. Ramirez, H. Dykstra, Y. Persidsky, D.N. Atochin, P.L. Huang, and V.R. Muzykantov Anti-inflammatory effect of targeted delivery of SOD to endothelium: mechanism, synergism with NO donors and protective effects in vitro and in vivo PLoS One 8 10 2013 e77002
268. M. Christofidou-Solomidou, A. Scherpereel, R. Wiewrodt, K. Ng, T. Sweitzer, E. Arguiri, V. Shuvaev, C.C. Solomides, S.M. Albelda, and V.R. Muzykantov PECAM-directed delivery of catalase to endothelium protects against pulmonary vascular oxidative stress Am. J. Physiol. Lung Cell Mol. Physiol. 285 2 2003 L283 L292
269. J. Han, V.V. Shuvaev, and V.R. Muzykantov Targeted interception of signaling reactive oxygen species in the vascular endothelium Ther. Deliv. 3 2 2012 263 276
270. S. Muro, M. Mateescu, C. Gajewski, M. Robinson, V.R. Muzykantov, and M. Koval Control of intracellular trafficking of ICAM-1-targeted nanocarriers by endothelial Na +/H + exchanger proteins Am. J. Physiol. Lung Cell Mol. Physiol. 290 5 2006 L809 L817
271. T.D. Dziubla, A. Karim, and V.R. Muzykantov Polymer nanocarriers protecting active enzyme cargo against proteolysis J. Control. Release 102 2 2005 427 439
272. E.A. Simone, T.D. Dziubla, E. Arguiri, V. Vardon, V.V. Shuvaev, M. Christofidou-Solomidou, and V.R. Muzykantov Loading PEG-catalase into filamentous and spherical polymer nanocarriers Pharm. Res. 26 1 2009 250 260
273. E.A. Simone, T.D. Dziubla, D.E. Discher, and V.R. Muzykantov Filamentous polymer nanocarriers of tunable stiffness that encapsulate the therapeutic enzyme catalase Biomacromolecules 2009
274. T.D. Dziubla, V.V. Shuvaev, N.K. Hong, B.J. Hawkins, M. Madesh, H. Takano, E. Simone, M.T. Nakada, A. Fisher, S.M. Albelda, and V.R. Muzykantov Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapies Biomaterials 29 2 2008 215 227
275. E.D. Hood, C.F. Greineder, C. Dodia, J. Han, C. Mesaros, V.V. Shuvaev, I.A. Blair, A.B. Fisher, and V.R. Muzykantov Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo J. Control. Release 2012
276. B.S. Ding, N. Hong, J.C. Murciano, K. Ganguly, C. Gottstein, M. Christofidou-Solomidou, S.M. Albelda, A.B. Fisher, D.B. Cines, and V.R. Muzykantov Prophylactic thrombolysis by thrombin-activated latent prourokinase targeted to PECAM-1 in the pulmonary vasculature Blood 111 4 2008 1999 2006
277. C.F. Greineder, A.M. Chacko, S. Zaytsev, B.J. Zern, R. Carnemolla, E.D. Hood, J. Han, B.S. Ding, C.T. Esmon, and V.R. Muzykantov Vascular immunotargeting to endothelial determinant ICAM-1 enables optimal partnering of recombinant scFv-thrombomodulin fusion with endogenous cofactor PLoS One 8 11 2013 e80110
278. C.F. Greineder, J.B. Brenza, R. Carnemolla, S. Zaitsev, E.D. Hood, D.C. Pan, B.S. Ding, C.T. Esmon, A.M. Chacko, and V.R. Muzykantov Dual targeting of therapeutics to endothelial cells: collaborative enhancement of delivery and effect FASEB J. 2015
279. M.C. Ferrer, V.V. Shuvaev, B.J. Zern, R.J. Composto, V.R. Muzykantov, and D.M. Eckmann Icam-1 targeted nanogels loaded with dexamethasone alleviate pulmonary inflammation PLoS One 9 7 2014 e102329
280. M.A. Hegeman, P.M. Cobelens, J. Kamps, M.P. Hennus, N.J.G. Jansen, M.J. Schultz, A.J. van Vught, G. Molema, and C.J. Heijnen Liposome-encapsulated dexamethasone attenuates ventilator-induced lung inflammation Br. J. Pharmacol. 163 5 2011 1048 1058
281. P.I. Homem de Bittencourt Jr., D.J. Lagranha, A. Maslinkiewicz, S.M. Senna, A.M. Tavares, L.P. Baldissera, D.R. Janner, J.S. Peralta, P.M. Bock, L.L. Gutierrez, G. Scola, T.G. Heck, M.S. Krause, L.A. Cruz, D.S. Abdalla, C.J. Lagranha, T. Lima, and R. Curi LipoCardium: endothelium-directed cyclopentenone prostaglandin-based liposome formulation that completely reverses atherosclerotic lesions Atherosclerosis 193 2 2007 245 258
282. S.A. Asgeirsdottir, P.J. Zwiers, H.W. Morselt, H.E. Moorlag, H.I. Bakker, P. Heeringa, J.W. Kok, C.G. Kallenberg, G. Molema, and J.A. Kamps Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded AbEsel liposomes Am. J. Physiol. Ren. Physiol. 294 3 2008 F554 F561
283. N. Hashida, N. Ohguro, N. Yamazaki, Y. Arakawa, E. Oiki, H. Mashimo, N. Kurokawa, and Y. Tano High-efficacy site-directed drug delivery system using sialyl-lewis X conjugated liposome Exp. Eye Res. 86 1 2008 138 149
284. M. Everts, G. Koning, R. Kok, S. Ásgeirsdóttir, D. Vestweber, D.F. Meijer, G. Storm, and G. Molema In vitro cellular handling and in vivo targeting of E-selectin-directed immunoconjugates and immunoliposomes used for drug delivery to inflamed endothelium Pharm. Res. 20 1 2003 64 72
285. S.A. Asgeirsdottir, J.A. Kamps, H.I. Bakker, P.J. Zwiers, P. Heeringa, K. van der Weide, H. van Goor, A.H. Petersen, H. Morselt, H.E. Moorlag, E. Steenbergen, C.G. Kallenberg, and G. Molema Site-specific inhibition of glomerulonephritis progression by targeted delivery of dexamethasone to glomerular endothelium Mol. Pharmacol. 72 1 2007 121 131
286. J.M. Kuldo, S.A. Asgeirsdottir, P.J. Zwiers, A.R. Bellu, M.G. Rots, J.A. Schalk, K.I. Ogawara, C. Trautwein, B. Banas, H.J. Haisma, G. Molema, and J.A. Kamps Targeted adenovirus mediated inhibition of NF-kappaB-dependent inflammatory gene expression in endothelial cells in vitro and in vivo J. Control. Release 166 1 2013 57 65
287. S.A. Asgeirsdottir, E.G. Talman, I.A. de Graaf, J.A. Kamps, S.C. Satchell, P.W. Mathieson, M.H. Ruiters, and G. Molema Targeted transfection increases siRNA uptake and gene silencing of primary endothelial cells in vitro - a quantitative study J. Control. Release 141 2 2010 241 251
288. J.E. Zuckerman, C.H.J. Choi, H. Han, and M.E. Davis Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane Proc. Natl. Acad. Sci. 109 8 2012 3137 3142
289. J.B. Lee, K. Zhang, Y.Y.C. Tam, Y.K. Tam, N.M. Belliveau, V.Y.C. Sung, P.J.C. Lin, E. LeBlanc, M.A. Ciufolini, P.S. Rennie, and P.R. Cullis Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo Int. J. Cancer 131 5 2012 E781 E790
290. G.A. Koning, R.M. Schiffelers, M.H.M. Wauben, R.J. Kok, E. Mastrobattista, G. Molema, T.L.M. ten Hagen, and G. Storm Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis Arthritis Rheum. 54 4 2006 1198 1208
291. P. Vader, B.J. Crielaard, S.M. van Dommelen, R. van der Meel, G. Storm, and R.M. Schiffelers Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particles J. Control. Release 160 2 2012 211 216
292. S. Muro New biotechnological and nanomedicine strategies for treatment of lysosomal storage disorders Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2 2 2010 189 204
293. E. Beutler Lysosomal storage diseases: natural history and ethical and economic aspects Mol. Genet. Metab. 88 3 2006 208 215
294. A.H. Futerman, and G. van Meer The cell biology of lysosomal storage disorders Nat. Rev. Mol. Cell Biol. 5 7 2004 554 565
295. P.J. Meikle, J.J. Hopwood, A.E. Clague, and W.F. Carey Prevalence of lysosomal storage disorders JAMA 281 3 1999 249 254
296. G.A. Grabowski Delivery of lysosomal enzymes for therapeutic use: glucocerebrosidase as an example Expert Opin. Drug Deliv. 3 6 2006 771 782
297. R.O. Brady, and R. Schiffmann Enzyme-replacement therapy for metabolic storage disorders Lancet Neurol. 3 12 2004 752 756
298. R.J. Desnick, and E.H. Schuchman Enzyme replacement and enhancement therapies: lessons from lysosomal disorders Nat. Rev. Genet. 3 12 2002 954 966
299. M.G. Rosenfeld, G. Kreibich, D. Popov, K. Kato, and D.D. Sabatini Biosynthesis of lysosomal hydrolases: their synthesis in bound polysomes and the role of co- and post-translational processing in determining their subcellular distribution J. Cell Biol. 93 1 1982 135 143
300. H. Du, M. Levine, C. Ganesa, D.P. Witte, E.S. Cole, and G.A. Grabowski The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy Am. J. Hum. Genet. 77 6 2005 1061 1074
301. E.F. Neufeld The uptake of enzymes into lysosomes: an overview Birth Defects Orig. Artic. Ser. 16 1 1980 77 84
302. S.R. Miranda, X. He, C.M. Simonaro, S. Gatt, A. Dagan, R.J. Desnick, and E.H. Schuchman Infusion of recombinant human acid sphingomyelinase into Niemann-Pick disease mice leads to visceral, but not neurological, correction of the pathophysiology FASEB J. 14 13 2000 1988 1995
303. XVI Chapter E.H. Schuchman, and R.J. Desnick C. Scriver, A. Beaudet, W. Sly, D. Valle, B. Childs, K. Kinzler, B. Vogelstein, Lysosomal Disorders. The Metabolic and Molecular Bases of Inherited Disease 8th ed. 2000 McGraw-Hill
304. J.S. Bae, K.H. Jang, T.R. Schuchman, and H.K. Jin Comparative effects of recombinant acid sphingomyelinase administration by different routes in Niemann-Pick disease mice Exp. Anim. 53 5 2004 417 421
305. S.D. Marlin, and T.A. Springer Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1) Cell 51 5 1987 813 819
306. M.P. Bevilacqua Endothelial-leukocyte adhesion molecules Annu. Rev. Immunol. 11 1993 767 804
307. S. Muro W.C. Aird, Endothelial Biomedicine 2007 Cambridge University Press 1058 1070
308. T. DeGraba, S. Azhar, F. Dignat-George, E. Brown, B. Boutiere, G. Altarescu, R. McCarron, and R. Schiffmann Profile of endothelial and leukocyte activation in Fabry patients Ann. Neurol. 47 2 2000 229 233
309. J. Hsu, D. Serrano, T. Bhowmick, K. Kumar, Y. Shen, Y.C. Kuo, C. Garnacho, and S. Muro Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease J. Control. Release 149 3 2011 323 331
310. J. Hsu, L. Northrup, T. Bhowmick, and S. Muro Enhanced delivery of α-glucosidase for Pompe disease by ICAM-1-targeted nanocarriers: comparative performance of a strategy for three distinct lysosomal storage disorders Nanomed. Nanotechnol. Biol. Med. 8 5 2012 731 739
311. J. Papademetriou, C. Garnacho, D. Serrano, T. Bhowmick, E.H. Schuchman, and S. Muro Comparative binding, endocytosis, and biodistribution of antibodies and antibody-coated carriers for targeted delivery of lysosomal enzymes to ICAM-1 versus transferrin receptor J. Inherit. Metab. Dis. 2012
312. C.T. Esmon Inflammation and thrombosis J. Thromb. Haemost. 1 7 2003 1343 1348
313. D.A. Dichek, J. Anderson, A.B. Kelly, S.R. Hanson, and L.A. Harker Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors Circulation 93 2 1996 301 309
314. V.R. Muzykantov, E.S. Barnathan, E.N. Atochina, A. Kuo, S.M. Danilov, and A.B. Fisher Targeting of antibody-conjugated plasminogen activators to the pulmonary vasculature J. Pharmacol. Exp. Ther. 279 2 1996 1026 1034
315. J.C. Murciano, S. Muro, L. Koniaris, M. Christofidou-Solomidou, D.W. Harshaw, S.M. Albelda, D.N. Granger, D.B. Cines, and V.R. Muzykantov ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface Blood 101 10 2003 3977 3984
316. B.S. Ding, C. Gottstein, A. Grunow, A. Kuo, K. Ganguly, S.M. Albelda, D.B. Cines, and V.R. Muzykantov Endothelial targeting of a recombinant construct fusing a PECAM-1 single-chain variable antibody fragment (scFv) with prourokinase facilitates prophylactic thrombolysis in the pulmonary vasculature Blood 106 13 2005 4191 4198
317. S.S. Husain Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities Biochemistry 30 23 1991 5797 5805
318. A. Ichinose, K. Fujikawa, and T. Suyama The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin J. Biol. Chem. 261 8 1986 3486 3489
319. W.P. Yang, J. Goldstein, R. Procyk, G.R. Matsueda, and S.Y. Shaw Design and evaluation of a thrombin-activable plasminogen activator Biochemistry 33 8 1994 606 612
320. C.T. Esmon Inflammation and the activated protein C anticoagulant pathway Semin. Thromb. Hemost. 32 Suppl 1 2006 49 60
321. Y.X. Wang, C. Wu, J. Vincelette, B. Martin-McNulty, S. Alexander, B. Larsen, D.R. Light, and K. McLean Amplified anticoagulant activity of tissue factor-targeted thrombomodulin: in-vivo validation of a tissue factor-neutralizing antibody fused to soluble thrombomodulin Thromb. Haemost. 96 3 2006 317 324
322. B.S. Ding, N. Hong, M. Christofidou-Solomidou, C. Gottstein, S.M. Albelda, D.B. Cines, A.B. Fisher, and V.R. Muzykantov Anchoring fusion thrombomodulin to the endothelial lumen protects against injury-induced lung thrombosis and inflammation Am. J. Respir. Crit. Care Med. 180 3 2009 247 256
323. J.W. Bulte, A.H. Schmieder, J. Keupp, S.D. Caruthers, S.A. Wickline, and G.M. Lanza MR cholangiography demonstrates unsuspected rapid biliary clearance of nanoparticles in rodents: implications for clinical translation Nanomedicine 2014